Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study - Concepedia

Concepedia

Publication | Closed Access

Long-Term Safety and Efficacy of a Once-Daily Formulation of Alfuzosin 10 mg in Patients with Symptomatic Benign Prostatic Hyperplasia: Open-Label Extension Study

57

Citations

24

References

2002

Year

Philip Van Kerrebroeck, A Jardin, Paul Van Cangh, K.U. Laval

European Urology

MedicineOnce-daily FormulationBenign Prostatic HyperplasiaPharmacotherapyLong-term SafetyProstatic DiseasePharmacologyAlfuzosin 10

References

	Year	Citations

Page 1